Arizona State Retirement System Increases Stake in The Cooper Companies, Inc. $COO

Arizona State Retirement System lifted its position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 108.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 110,873 shares of the medical device company's stock after purchasing an additional 57,621 shares during the quarter. Arizona State Retirement System owned 0.06% of Cooper Companies worth $7,951,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in the company. West Family Investments Inc. acquired a new stake in shares of Cooper Companies during the 2nd quarter valued at about $551,000. Waverly Advisors LLC boosted its position in Cooper Companies by 1,180.4% during the second quarter. Waverly Advisors LLC now owns 58,360 shares of the medical device company's stock worth $4,185,000 after purchasing an additional 53,802 shares in the last quarter. Empirical Finance LLC grew its holdings in Cooper Companies by 193.5% in the second quarter. Empirical Finance LLC now owns 19,908 shares of the medical device company's stock valued at $1,428,000 after purchasing an additional 13,124 shares during the period. Nykredit A S purchased a new stake in shares of Cooper Companies in the second quarter valued at approximately $5,715,000. Finally, Parkside Financial Bank & Trust increased its position in shares of Cooper Companies by 97.4% in the second quarter. Parkside Financial Bank & Trust now owns 1,929 shares of the medical device company's stock valued at $138,000 after buying an additional 952 shares in the last quarter. 24.39% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting Cooper Companies

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Cooper reported fiscal Q3 adjusted EPS of $1.15, above the $1.12 consensus estimate. The company also generated $273 million in free cash flow and repurchased $339.1 million of stock. CooperCompanies Announces Third Quarter 2026 Results
• Positive Sentiment: The board increased its share-repurchase authorization from $2 billion to $3 billion, potentially allowing repurchases of up to 22.7% of outstanding shares and signaling that management views the stock as undervalued. CooperCompanies Completes Strategic Review
• Neutral Sentiment: Analysts remain divided: Needham maintained a “buy” rating despite lowering its target to $73, while JPMorgan, UBS and Bank of America cut targets and maintained neutral ratings. The revisions imply upside from recent levels but reflect reduced estimates and greater uncertainty.
• Negative Sentiment: Revenue totaled approximately $1.066 billion, below the $1.10 billion consensus, with CooperVision revenue flat year over year. Destocking and channel-inventory reductions in the U.S. pressured contact-lens demand and overshadowed the EPS beat. COO Q3 Earnings Top Estimates
• Negative Sentiment: Cooper cut fiscal 2026 adjusted EPS guidance to $4.51–$4.55 from expectations near $4.63, and forecast fourth-quarter EPS of $1.05–$1.09 versus consensus of $1.20. Investors also reacted negatively to the decision not to pursue a sale of CooperSurgical after the strategic review. Cooper Cos. Stock Drops After Soft Outlook
• Negative Sentiment: A securities-fraud investigation announced by the Law Offices of Frank R. Cruz adds headline and legal risk, although the announcement does not establish that Cooper violated securities laws. Securities Fraud Investigation Announcement

Analyst Ratings Changes

A number of research analysts have recently issued reports on COO shares. Needham & Company LLC decreased their target price on Cooper Companies from $86.00 to $73.00 and set a "buy" rating on the stock in a research report on Thursday. Weiss Ratings reissued a "sell (d)" rating on shares of Cooper Companies in a research note on Friday, September 4th. The Goldman Sachs Group set a $61.00 target price on shares of Cooper Companies in a research report on Wednesday, May 27th. Mizuho set a $75.00 price target on shares of Cooper Companies in a research note on Thursday. Finally, UBS Group lowered their price target on shares of Cooper Companies from $75.00 to $66.00 and set a "neutral" rating on the stock in a research report on Thursday. Five analysts have rated the stock with a Buy rating, eleven have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus target price of $71.47.

Cooper Companies Stock Down 14.7%

NASDAQ COO opened at $54.17 on Friday. The business's fifty day simple moving average is $72.02 and its 200-day simple moving average is $69.81. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23. The firm has a market cap of $10.56 billion, a PE ratio of 18.49, a P/E/G ratio of 1.66 and a beta of 0.82. The Cooper Companies, Inc. has a 52 week low of $51.01 and a 52 week high of $89.83.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Wednesday, September 9th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.12 by $0.03. Cooper Companies had a net margin of 13.46% and a return on equity of 10.92%. The firm had revenue of $1.07 billion during the quarter, compared to analyst estimates of $1.10 billion. During the same quarter in the prior year, the firm posted $0.49 earnings per share. Cooper Companies's quarterly revenue was up .5% on a year-over-year basis. Cooper Companies has set its Q4 2026 guidance at 1.050-1.090 EPS and its FY 2026 guidance at 4.510-4.550 EPS. As a group, equities analysts anticipate that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

Cooper Companies announced that its Board of Directors has initiated a share buyback program on Wednesday, September 9th that permits the company to buyback $3.00 billion in shares. This buyback authorization permits the medical device company to reacquire up to 22.7% of its stock through open market purchases. Stock buyback programs are often a sign that the company's board of directors believes its shares are undervalued.

About Cooper Companies

Cooper Companies, Inc is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company develops, manufactures and markets products through two primary business segments: CooperVision and CooperSurgical.

CooperVision specializes in contact lenses, including daily disposable, toric, multifocal, multifocal toric, specialty and myopia-management lenses. Its products are designed to address a range of vision-correction needs, including astigmatism, presbyopia and irregular corneas.

Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.